242 related articles for article (PubMed ID: 21040309)
1. Non-surgical treatments of primary, non-melanoma eyelid malignancies: a review.
Murchison AP; Walrath JD; Washington CV
Clin Exp Ophthalmol; 2011 Jan; 39(1):65-83; quiz 92-3. PubMed ID: 21040309
[TBL] [Abstract][Full Text] [Related]
2. Periocular cutaneous malignancies: a review of the literature.
Slutsky JB; Jones EC
Dermatol Surg; 2012 Apr; 38(4):552-69. PubMed ID: 22404129
[TBL] [Abstract][Full Text] [Related]
3. Periocular skin cancer: Diagnosis and management.
Moran JM; Phelps PO
Dis Mon; 2020 Oct; 66(10):101046. PubMed ID: 32600650
[TBL] [Abstract][Full Text] [Related]
4. Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K; Yasumatsu R; Toh S; Shiratsuchi H; Yoshida T; Nishiyama K; Yoshikawa H; Nakashima T; Nakagawa T
Auris Nasus Larynx; 2016 Dec; 43(6):666-71. PubMed ID: 26965587
[TBL] [Abstract][Full Text] [Related]
5. Eyelid and ocular surface carcinoma: diagnosis and management.
Yin VT; Merritt HA; Sniegowski M; Esmaeli B
Clin Dermatol; 2015; 33(2):159-69. PubMed ID: 25704936
[TBL] [Abstract][Full Text] [Related]
6. Oculoplastic aspects of ocular oncology.
Rene C
Eye (Lond); 2013 Feb; 27(2):199-207. PubMed ID: 23196649
[TBL] [Abstract][Full Text] [Related]
7. Treatment options and future prospects for the management of eyelid malignancies: an evidence-based update.
Cook BE; Bartley GB
Ophthalmology; 2001 Nov; 108(11):2088-98; quiz 2099-100, 2121. PubMed ID: 11713084
[TBL] [Abstract][Full Text] [Related]
8. Cutaneous malignancies: BCC, SCC, and MM.
Vargo N
Dermatol Nurs; 2006 Apr; 18(2):183, 200. PubMed ID: 16708685
[No Abstract] [Full Text] [Related]
9. Sebaceous carcinoma of the ocular region: a review.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Surv Ophthalmol; 2005; 50(2):103-22. PubMed ID: 15749305
[TBL] [Abstract][Full Text] [Related]
10. Socioeconomic and Ethnic Disparities in Periocular Cutaneous Malignancies.
Broadbent T; Bingham B; Mawn LA
Semin Ophthalmol; 2016; 31(4):317-24. PubMed ID: 27099991
[TBL] [Abstract][Full Text] [Related]
11. Treatment of skin malignancies.
Reynolds PL; Strayer SM
J Fam Pract; 2003 Jun; 52(6):456-64. PubMed ID: 12791228
[TBL] [Abstract][Full Text] [Related]
12. [Topical therapy of squamous cell carcinoma].
Hengge UR
Hautarzt; 2007 May; 58(5):412-8. PubMed ID: 17429585
[TBL] [Abstract][Full Text] [Related]
13. The molecular genetics of eyelid tumors: recent advances and future directions.
Milman T; McCormick SA
Graefes Arch Clin Exp Ophthalmol; 2013 Feb; 251(2):419-33. PubMed ID: 23275038
[TBL] [Abstract][Full Text] [Related]
14. Management of nonmelanoma skin cancer in 2007.
Neville JA; Welch E; Leffell DJ
Nat Clin Pract Oncol; 2007 Aug; 4(8):462-9. PubMed ID: 17657251
[TBL] [Abstract][Full Text] [Related]
15. Advances in Immunotherapy and Periocular Malignancy.
Habib LA; Wolkow N; Freitag SK; Yoon MK
Semin Ophthalmol; 2019; 34(4):327-333. PubMed ID: 31177931
[TBL] [Abstract][Full Text] [Related]
16. Non-melanoma skin cancers: photodynamic therapy, cryotherapy, 5-fluorouracil, imiquimod, diclofenac, or what? Facts and controversies.
Bahner JD; Bordeaux JS
Clin Dermatol; 2013; 31(6):792-8. PubMed ID: 24160289
[TBL] [Abstract][Full Text] [Related]
17. Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid.
Apalla Z; Karteridou A; Lallas A; Tzellos T; Lefaki I; Sotiriou E; Varytimiadis D
Dermatol Surg; 2013 Jan; 39(1 Pt 1):146-7. PubMed ID: 23301789
[No Abstract] [Full Text] [Related]
18. [Therapy of non-melanocytic skin tumors].
Hafner J
Ther Umsch; 1998 Aug; 55(8):515-21. PubMed ID: 9757819
[TBL] [Abstract][Full Text] [Related]
19. The effective treatment of basal cell carcinoma.
Skelton LA
Br J Nurs; 2009 Mar 26-Apr 8; 18(6):346, 348-50. PubMed ID: 19329898
[TBL] [Abstract][Full Text] [Related]
20. Kissing tumors of sebaceous carcinoma on the eyelids in collision with melanocytic nevus: A case report.
Lin YC; Chen WC; Wu CS; Liao JB; Wei KC
J Dermatol; 2016 Apr; 43(4):447-9. PubMed ID: 26661447
[No Abstract] [Full Text] [Related]
[Next] [New Search]
